Literature DB >> 2025951

Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE).

J M van der Zee1, C E Siegert, T A de Vreede, M R Daha, F C Breedveld.   

Abstract

IgG anti-endothelial antibodies (AEA), as measured by ELISA or immunoblotting technique could be detected in serum samples of 56 out of 64 patients with SLE (88%) and mainly occurred in monomeric form. AEA were not cell specific, because the binding reactivity was absorbed partially by both fibroblasts and peripheral blood mononuclear cells. No correlation was found between the presence of AEA and anti-nuclear antibodies. Immunoblotting revealed reactivity of AEA against endothelial antigens ranging in size from 15 to 200 kD. AEA titres were significantly higher in patients with joint or skin abnormalities, compared with patients without these abnormalities. A significant correlation was found between nephritis in SLE and the presence of AEA reactivity against endothelial membrane antigens of 38, 41 and 150 kD. These data show that the pattern of AEA reactivity in serum of SLE patients is heterogeneous, and suggest that AEA against a limited number of antigens may be involved in the pathogenesis of nephritis in SLE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025951      PMCID: PMC1535404          DOI: 10.1111/j.1365-2249.1991.tb08155.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.

Authors:  D Y Leung; T Collins; L A Lapierre; R S Geha; J S Pober
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

3.  Cross--reactivity of antilymphocyte and antinuclear antibodies in systemic lupus erythematosus.

Authors:  R P Searles; R P Messner; A D Bankhurst
Journal:  Clin Immunol Immunopathol       Date:  1979-11

4.  The lupus activity criteria count (LACC).

Authors:  M B Urowitz; D D Gladman; E C Tozman; C H Goldsmith
Journal:  J Rheumatol       Date:  1984-12       Impact factor: 4.666

Review 5.  Antibodies against renal endothelial alloantigens.

Authors:  L C Paul; C B Carpenter
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Useful laboratory measurements in the management of systemic lupus erythematosus.

Authors:  W J Morrow; D A Isenberg; A Todd-Pokropek; H F Parry; M L Snaith
Journal:  Q J Med       Date:  1982

8.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation.

Authors:  S C Thornton; S N Mueller; E M Levine
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

9.  Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.

Authors:  E R Burns; D Zucker-Franklin
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

10.  The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.

Authors:  R M Valentijn; H van Overhagen; H M Hazevoet; J Hermans; A Cats; M R Daha; L A van ES
Journal:  Arthritis Rheum       Date:  1985-08
View more
  15 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Antiendothelial cell antibodies in vasculitis and connective tissue disease.

Authors:  C Belizna; A Duijvestijn; M Hamidou; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 3.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 4.  Microvascular involvement in systemic sclerosis and systemic lupus erythematosus.

Authors:  Didem Saygin; Kristin B Highland; Adriano R Tonelli
Journal:  Microcirculation       Date:  2019-04       Impact factor: 2.628

Review 5.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

6.  Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.

Authors:  H Ihn; S Sato; M Fujimoto; A Igarashi; N Yazawa; M Kubo; K Kikuchi; K Takehara; K Tamaki
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Takaono; K Iwasaki; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

8.  IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.

Authors:  D Carvalho; C O Savage; C M Black; J D Pearson
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

9.  Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS).

Authors:  M B Hill; J L Phipps; R G Malia; M Greaves; P Hughes
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

10.  Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis.

Authors:  J R Westphal; A M Boerbooms; C J Schalwijk; H Kwast; M De Weijert; C Jacobs; G Vierwinden; D J Ruiter; L B Van de Putte; R M De Waal
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.